Insurer says initial approval to cover cystic fibrosis medication was due to 'system timing error'
Concerns about prescribing practices, costs, and lack of evidence are giving companies pause
The benefits to employers and employees could outweigh the risks
Analytics firm calls for action on drug costs that are becoming out of reach for many employers
‘Unsustainable’ drug price increases predicted to drive up private insurance premiums, say industry body
Advisors are increasingly caught between angry clients and carriers unable or unwilling to explain a variance in premiums for stop-loss coverage.